Vernalis
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Granta Park, Cambridge, Cambridgeshire, ...Phone Number
+44 1223895555Website
www.vernalis.comRevenue
$25.3 MillionIndustry
About Vernalis
Vernalis specializes in drug discovery, collaborating with various organizations to support both short- and long-term projects. With over twenty-five years of expertise in structure-based drug discovery, they offer services including protein expression, hit identification, and lead optimization. Their innovative approach combines fragment-based methods, DNA Encoded Library technology, and virtual screening to deliver validated chemical matter to partners. Vernalis has a proven track record of working with notable collaborators such as Servier and Genentech to tackle challenging therapeutic targets.Explore more
Vernalis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vernalis
Compare insights from companies similar to Vernalis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vernalis Tech Stack
A closer look at the technologies used by Vernalis
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vernalis
Sign Up For FreeTo access detailed company insights
Vernalis specializes in drug discovery, collaborating with various organizations to support both short- and long-term projects. With over twenty-five years of expertise in structure-based drug discovery, they offer services including protein expression, hit identification, and lead optimization. Their innovative approach combines fragment-based met... Read More
